In this article, we break down the Top 5 Healthcare Stocks According to Goldman Sachs. For investors looking for the complete list, you can explore our full report on the Top 10 Healthcare Stocks According to Goldman Sachs.
5. Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT), trading at $108.61, continues to reinforce its position as one of the most diversified and globally resilient healthcare companies, with its latest move underscoring a strategic push into high-growth international markets. In what seasoned observers of the global healthcare sector would describe as a calculated expansion, Abbott recently confirmed the launch of its next-generation XIENCE Skypoint stent in India—one of the world’s fastest-growing healthcare markets.
For investors closely tracking healthcare stocks and medical device companies, this development carries more weight than a routine product rollout. Cardiovascular disease remains one of the leading causes of death globally, and demand for advanced interventional cardiology solutions continues to rise, particularly in emerging economies where healthcare infrastructure is rapidly evolving. Abbott’s XIENCE Skypoint is specifically engineered to navigate complex coronary anatomies, offering enhanced flexibility and precision in treating difficult arterial blockages.
What sets this innovation apart is not merely its technical refinement but its broader clinical and economic implications. The stent’s slim and highly deliverable design allows physicians to treat long lesions more effectively, potentially reducing the number of stents required per procedure. This translates into improved patient outcomes and cost efficiencies—two critical factors shaping modern healthcare systems.
Abbott’s strategy aligns with a broader industry trend where global healthcare companies are increasingly targeting emerging markets to drive long-term growth. As one of the most searched names in healthcare stocks and medical device investments, Abbott benefits from a diversified portfolio that spans diagnostics, nutrition, branded generics, and devices. This multi-segment approach provides a level of stability that few competitors can match, making it a consistent presence in discussions around best healthcare stocks to buy and long-term investment opportunities in healthcare.
Click next to see the following stock...
